Log in to save to my catalogue

Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY exte...

Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY exte...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2673451139

Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience

About this item

Full title

Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience

Publisher

New York: Springer US

Journal title

Pituitary, 2022-06, Vol.25 (3), p.420-432

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose
To report the effects of pegvisomant (PEGV) treatment on patient-reported outcomes in acromegaly patients.
Methods
We conducted an extension study of an open-label, multinational, non-interventional study (ACROSTUDY) evaluating the long-term safety and efficacy of PEGV for acromegaly in routine clinical practice. Enrolled patients...

Alternative Titles

Full title

Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2673451139

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2673451139

Other Identifiers

ISSN

1386-341X

E-ISSN

1573-7403

DOI

10.1007/s11102-022-01206-2

How to access this item